If you were regularly exposed to Roundup weedkiller and were later diagnosed with non-Hodgkin lymphoma, you may qualify for compensation.
Roundup is a widely used weedkiller made by Monsanto (now owned by Bayer) whose active ingredient, glyphosate, is the subject of thousands of lawsuits. Plaintiffs allege long-term exposure to Roundup is linked to non-Hodgkin lymphoma, and that Monsanto failed to warn users of the risk.
As of mid-2026, thousands of Roundup cases remain pending in both federal multidistrict litigation and state courts, even after Monsanto has already settled roughly two-thirds of all claims filed to date.
Here's what happens after you reach out:
A short set of free eligibility questions about your situation — takes about two minutes.
Our network reviews your answers against current qualifying criteria and reaches out if you may qualify.
You decide whether to move forward. There's never a cost to check your eligibility.
As of July 2026, there are roughly 3,900 Roundup lawsuits pending in the federal MDL (N.D. Cal., Judge Vince Chhabria), with thousands more in state courts. Monsanto has reached settlements in nearly 100,000 cases totaling about $11 billion, but an estimated 61,000 claims remain active. A contested $7.25 billion proposed class settlement for future claims received preliminary approval in Missouri state court in March 2026. Separately, the U.S. Supreme Court heard oral arguments in Monsanto v. Durnell on April 27, 2026 — a ruling is still pending and could significantly affect whether failure-to-warn claims can proceed nationwide.
Monsanto v. Durnell, argued before the Supreme Court in April 2026, could determine whether Roundup failure-to-warn claims are allowed to proceed under federal law. A ruling is still pending as of this writing — it's one of the most consequential open questions in this litigation right now.
A Missouri court delayed the final approval hearing for Bayer's $7.25 billion Roundup settlement to September 14, giving more time to resolve opt-out disputes.
Read more →A Missouri judge set August 19, 2026 as the new final approval hearing date for Bayer's $7.25 billion Roundup class settlement, following objections and a favorable Supreme Court ruling for Bayer.
Read more →Bayer's proposed $7.25 billion Roundup class settlement headed to a July 9, 2026 fairness hearing facing more than 100 objections over its opt-out process, attorney fees, and a novel future-claimants subclass.
Read more →Get updates on Roundup, plus other case types we cover.
We'll keep you updated on Roundup and other case types.